TABLE 2.

The outcome of mice vaccinated and treated with finafloxacin^a

		Unvaccinated	Vaccinated	Total
Outcome	Survived with no detectable bacteria within organs	$n=1$ $5\%\downarrow$ $1.7\%total$	$n=18$ $45\%\downarrow$ $30\%total$	$n=19$ $31.7\%total$
	Survived and colonized with bacteria	$n=9$ $45\%\downarrow$ $15\%total$	$n=8$ $20\%\downarrow$ $13.3\%total$	$n=17$ $28.3\%total$
	Culled	$n=10$ $50\%\downarrow$ $16.7\%total$	$n=14$ $35\%\downarrow$ $23.3\%total$	$n=24$ $40\%total$
Total		$n=20$ $33.3\%total$	$n=40$ $66.7\%total$	$n=60$ $100\%total$

^a The outcome data from Fig. 4 (not including those mice culled to after cessation of antibiotics) were analyzed by an ordinal general linear model. Data are shown as the frequency (n), the percent column total (↓), and the percent overall total (total). This includes vaccine data with and without CpG and finafloxacin initiated at 36 and 48 h post-challenge. Neither the treatment time or the addition of CpG impacted on this model and is not included in these frequencies.